K Nasu

1.5k total citations
51 papers, 1.2k citations indexed

About

K Nasu is a scholar working on Pathology and Forensic Medicine, Genetics and Hematology. According to data from OpenAlex, K Nasu has authored 51 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Pathology and Forensic Medicine, 18 papers in Genetics and 16 papers in Hematology. Recurrent topics in K Nasu's work include Lymphoma Diagnosis and Treatment (23 papers), Chronic Lymphocytic Leukemia Research (15 papers) and T-cell and Retrovirus Studies (10 papers). K Nasu is often cited by papers focused on Lymphoma Diagnosis and Treatment (23 papers), Chronic Lymphocytic Leukemia Research (15 papers) and T-cell and Retrovirus Studies (10 papers). K Nasu collaborates with scholars based in Japan and United States. K Nasu's co-authors include Dianne Sako, Marshall E. Kadin, Jonathan W. Said, Eric C. Vonderheid, Chikara Sakai, Kazuhiro Tashiro, Takuhei Murase, Tohru Inaba, Hidehiko Saito and Kiyotaka Kawauchi and has published in prestigious journals such as Blood, Cancer and Journal of Virology.

In The Last Decade

K Nasu

49 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K Nasu Japan 19 594 393 291 275 263 51 1.2k
DY Mason United Kingdom 10 770 1.3× 438 1.1× 266 0.9× 458 1.7× 121 0.5× 13 1.3k
RK Brynes United States 19 555 0.9× 375 1.0× 325 1.1× 451 1.6× 117 0.4× 37 1.2k
DY Mason United Kingdom 7 1.2k 2.1× 673 1.7× 372 1.3× 688 2.5× 235 0.9× 9 1.8k
A. Le Tourneau France 20 460 0.8× 217 0.6× 263 0.9× 379 1.4× 94 0.4× 83 1.2k
LoAnn C. Peterson United States 20 562 0.9× 345 0.9× 542 1.9× 260 0.9× 78 0.3× 35 1000
Shigehiko Ishihara Japan 18 434 0.7× 557 1.4× 160 0.5× 655 2.4× 94 0.4× 41 1.2k
T Radaszkiewicz Austria 28 1.2k 2.0× 897 2.3× 407 1.4× 603 2.2× 135 0.5× 66 2.4k
Carlo D. Baroni Italy 24 700 1.2× 451 1.1× 265 0.9× 695 2.5× 520 2.0× 75 1.9k
Henry Y. Dong United States 17 741 1.2× 227 0.6× 388 1.3× 693 2.5× 111 0.4× 35 1.3k
Daniel Catovsky United Kingdom 23 636 1.1× 963 2.5× 522 1.8× 349 1.3× 61 0.2× 47 1.7k

Countries citing papers authored by K Nasu

Since Specialization
Citations

This map shows the geographic impact of K Nasu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K Nasu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K Nasu more than expected).

Fields of papers citing papers by K Nasu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K Nasu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K Nasu. The network helps show where K Nasu may publish in the future.

Co-authorship network of co-authors of K Nasu

This figure shows the co-authorship network connecting the top 25 collaborators of K Nasu. A scholar is included among the top collaborators of K Nasu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K Nasu. K Nasu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Hirose, Yuko, Masayuki Sano, Haruhiko Fukuda, et al.. (2006). A Phase II Study of VEPA/FEPP Chemotherapy for Aggressive Lymphoma in Elderly Patients: Japan Clinical Oncology Group Study JCOG9203. International Journal of Hematology. 83(1). 55–62. 6 indexed citations
3.
Nishii, Kazuhiro, Eiji Usui, Naoyuki Katayama, et al.. (2003). Characteristics of t(8;21) acute myeloid leukemia (AML) with additional chromosomal abnormality: concomitant trisomy 4 may constitute a distinctive subtype of t(8;21) AML. Leukemia. 17(4). 731–737. 46 indexed citations
4.
Nishii, Kazuhiro, Naoyuki Katayama, Hiroto Miwa, et al.. (2002). Non-DNA-binding Ikaros isoform gene expressed in adult B-precursor acute lymphoblastic leukemia. Leukemia. 16(7). 1285–1292. 30 indexed citations
5.
Shintaku, Masayuki, et al.. (2001). Aortic lesions in aspergillosis: histopathological study of two autopsy cases. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 439(5). 640–644. 2 indexed citations
6.
Kimura, Hideo, K Nasu, Chikara Sakai, et al.. (1998). Histiocytic Sarcoma of the Spleen Associated with Hypoalbuminemia, Hypo γ-globulinemia and Thrombocytopenia as a Possibly Unique Clinical Entity-Report of Three Cases. Leukemia & lymphoma. 31(1-2). 217–224. 20 indexed citations
7.
Miwa, Hiroto, Minoru Mizutani, Nadim Mahmud, et al.. (1998). Biphasic expression of CD4 in acute myelocytic leukemia (AML) cells: AML of monocyte origin and hematopoietic precursor cell origin. Leukemia. 12(1). 44–51. 23 indexed citations
8.
Ohta, Hitoya, Akihito Yonezawa, K Nasu, & Masayuki Shintaku. (1997). 111In-chloride uptake In pulmonary aspergillosis. Annals of Nuclear Medicine. 11(2). 151–153. 4 indexed citations
9.
Nakase, Kazunori, Kenkichi Kita, Hiroshi Shiku, et al.. (1996). Myeloid Antigen, CD13, CD14, and/or CD33 Expression Is Restricted to Certain Lymphoid Neoplasms. American Journal of Clinical Pathology. 105(6). 761–768. 31 indexed citations
10.
Nakase, Kazunori, Kenkichi Kita, K Nasu, et al.. (1994). Differential expression of interleukin‐2 receptors (α and β chain) in mature lymphoid neoplasms. American Journal of Hematology. 46(3). 179–183. 38 indexed citations
11.
Shintaku, Masayuki, K Nasu, & Masafumi Ito. (1993). Necrotizing tubulo‐interstitial nephritis induced by adenovirus in an AIDS patient. Histopathology. 23(6). 588–590. 13 indexed citations
12.
Shintaku, Masayuki, K Nasu, & Takeshi Shimizu. (1993). Fulminant hepatic failure in an AIDS patient: possible zidovudine-induced hepatotoxicity.. PubMed. 88(3). 464–6. 8 indexed citations
13.
Nakase, Kazunori, Shigeru Shirakawa, K Nasu, et al.. (1993). Interleukin-2 receptor alpha chain on acute myelocytic leukemia cells is involved in cell-to-cell interactions. Leukemia Research. 17(1). 17–21. 10 indexed citations
14.
Kita, Kenkichi, Hideyuki Saya, Masahiro Masuya, et al.. (1992). Structural alterations of the p53 gene in human leukemias. Leukemia Research. 16(11). 1105–1112. 6 indexed citations
15.
Nakase, Kazunori, Kenkichi Kita, Shigeru Shirakawa, et al.. (1992). Diagnostic and clinical importance of interleukin‐2 receptor alpha chain expression on non‐T‐cell acute leukaemia cells. British Journal of Haematology. 80(3). 317–326. 37 indexed citations
16.
Ikeda, Takeshi, Kenkichi Kita, Keiki Kawakami, et al.. (1990). Oligoclonal Immunoglobulin Gene Rearrangements in Philadelphia Chromosome‐positive Common Acute Lymphoblastic Leukemia. Japanese Journal of Cancer Research. 81(4). 340–344. 2 indexed citations
17.
Ikekubo, K, Megumu Hino, Hideki Ito, et al.. (1988). The Development of a Solitary Toxic Thyroid Nodule Following Graves?? Disease. Clinical Nuclear Medicine. 13(10). 748–750. 1 indexed citations
18.
Kita, K, H Kamesaki, Doi S, et al.. (1986). Blast crisis in chronic myelocytic leukemia with blasts expressing both lymphoid and myeloid antigens.. PubMed. 49(4). 885–93. 3 indexed citations
19.
Kita, K, K Nasu, H Kamesaki, et al.. (1985). Phenotypic characterization and clinical evaluation of 15 patients with lymphoblastic lymphoma.. PubMed. 48(1). 89–98. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026